Offer Information

Filter by

Practice Area

Search Insights:
Showing 1 to 10 of 61
Filter by: Offer Information

Brochure

About Kantar Health

Kantar Health is the one organization that healthcare companies can count on to get an informed answer to their product development, launch and brand questions. We combine evidence-based research with deep clinical, commercial and brand expertise to help our clients assess market opportunities, prioritize product development and portfolio activities, and differentiate their products to drive brand success.

View PDF | | Share

Datasheet

Brand Equity Assessment

Kantar Health’s framework for brand growth, PINNAKLE®, uncovers unrealized brand opportunity, measures and optimizes brand performance, and improves customer experience across the product lifecycle.

View PDF | | Share

Fact Sheet

Business Development & Licensing

The constantly changing pharma market brings unique challenges to your business development and licensing initiatives. Kantar Health offers a wide range of services spanning the business development process - from strategic planning to translation support as well as custom consulting to meet your specific needs.

View PDF | | Share

Datasheet

CancerLandscape™

CancerLandscape™ is a web-based platform that allows users to quickly review more than 6,000 cancer drugs simultaneously. It combines multiple primary and secondary data sources so users can quickly navigate product opportunities within the cancer landscape.

View PDF | | Share

Fact Sheet

CancerMPact®

CancerMPact® is an invaluable and comprehensive oncology decision support resource. It can be utilized for market analysis, strategic planning and identification of commercial opportunities in the U.S., Western Europe, Japan and China.

View PDF | | Share

Fact Sheet

CancerMPact® Biomarker Analysis

Biomarker Analysis is a global resource based on a thorough review of literature and recently published data that discusses the current and evolving oncology landscape with regard to biomarker segmentation and geographic, survival, ethnic, racial and gender differences.

View PDF | | Share

Fact Sheet

CancerMPact® Future Trends and Insights

Future Trends and Insights explores potential changes in treatment practices in the U.S., Western Europe and Japan based on a critical evaluation of recently published clinical data, regulatory advances/setbacks and ongoing clinical trials.

View PDF | | Share

Datasheet

CancerMPact® Patient Metrics – China

Patient Metrics – China combines epidemiologic data and analysis to estimate incidence (annual new cases of cancer) by stage; restaged 10-year prevalence, active disease, and treated patient populations by modality (surgery, radiation, drug therapy, etc.), drug regimens, and drug agents.

View PDF | | Share

Fact Sheet

CancerMPact® Patient Metrics – Expanded Markets

Patient Metrics – Expanded Markets provides broad coverage combined with deep understanding of the epidemiology of cancer and includes analysis of 17 tumor types by country for Argentina, Brazil, Canada, India, Mexico, Russia, South Korea, Taiwan and Turkey.

View PDF | | Share

Datasheet

CancerMPact® Patient Metrics – G7

Patient Metrics – G7 combines epidemiologic data and analysis to estimate incidence by stage; restaged 10-year prevalence; active disease; and treated patient populations by modality, drug regimens, and drug agents.

View PDF | | Share
Page  < 1234567 >